As per annexure enclosed

APOLLO HOSPITALS ENTERPRISE LIMITED l?osPITALS CIN:L85110TN1979PLC008035 October 15, 2026 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Sandra - Kurla Complex Scrip Code - 508869 Sandra (E) ISIN INE437A01024 Mumbai - 400 051. Scrip Code APOLLOHOSP ISIN INE437A01024 Dear Sirs, Subject: Disclosure under Regulation 30 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a conference call for the analysts/investors is scheduled to be held on Thursday, 5th November 2026 at 3.00 p.m. to discuss the unaudited financial results for the three and six months ended 30th September 2026. Pl. find enclosed the details of conference call for your reference. Kindly take this on record. Thanking you, S.M. KRISHNAN'· Sr. VICE PRESIDENT - FINANCE AND COMPANY SECRETARY IS/ISO 9001 : 2000 Regd. Office : General Office : Tel : 044 - 28290956 / 3896 / 6681 19, Bishop Gardens, "Ali Towers" Ill Floor, Telefax : 044 - 2829 0956 Raja Annamalaipuram, #55, Greams Road, Email : investor.relations@apollohospitals.com Chennai - 600 028. Chennai - 600 006. Website : www.apollohospitals.com AAollo ROSPITALS r c , s Apollo Hospitals Enterprise Limited to host Q2 FY27 Earnings Conference Call on Thursday, 5 November, 2026 at 3:00 PM IST Apollo Hospitals Enterprise Ltd. will organize a conference call for investors on November 5, 2026 at 3:00 PM IST. AHEL will be represented by: Mrs. Suneeta Reddy – Managing Director Mr. A. Krishnan – Group CFO Dr. Madhu Sasidhar – President & CEO Hospitals Division Mr. Madhivanan Balakrishnan – CEO of Apollo HealthCo Ltd. Mr. Sriram Iyer – CEO of AHLL Mr. Sanjiv Gupta – CFO of Apollo HealthCo Ltd. Mr. Obul Reddy – CFO of Pharmacy business The conference call follows the announcement of AHEL’s financial results for the quarter ended September 30, 2026 which will be announced on Wednesday, November 4, 2026. The financial results along with the earnings presentation will be available on the corporate website: www.apollohospitals.com. Details of the conference call are as follows: Timing • 3:00 PM IST on Thursday, November 5, 2026 Conference dial-in: Primary number • +91 22 6280 1141 / +91 22 7115 8042 Singapore Toll Free Number • 800 101 2045 Hong Kong Toll Free Number • 800 964 448 USA Toll Free Number • 1 866 746 2133 UK Toll Free Number • 0 808 101 1573 To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Oick hereto ExpressJoin the Call Pre-registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call - ENDS - For further information please contact R Krishnakumar Mayank Vaswani Apollo Hospitals Ltd. CDR, India Tel: +91 44 2829 7840 Tel: +91 98209 40953 email: krishnakumar_r@apollohospitals.com email: mayank@cdr-india.com About Apollo Hospitals Enterprise Ltd. (AHEL) Apollo revolutionized healthcare when Dr Prathap Reddy opened the first hospital in Chennai in 1983. Today Apollo is the world's largest integrated healthcare platform with over 10,000 beds across 73 hospitals, over 6000 pharmacies and over 2500 clinics and diagnostic centers as well as 500+ telemedicine centers. Since its inception, Apollo has emerged as one of the world's premier cardiac centers, having conducted over 300,000 angioplasties and 200,000 surgeries. Apollo continues to invest in research to bring the most cutting-edge technologies, equipment and treatment protocols to ensure patients have the best available care in the world. Apollo's 100,000 family members are dedicated to bringing you the best care and leaving the world better than we found it. Note: This invite is intended solely for the use of the named addressee(s). Any distribution of this invite is strictly prohibited by the sender. If you are not the intended recipient, we request you to notify the sender immediately and delete this document.